These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19219342)

  • 21. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
    J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
    Lazar L; Kauli R; Pertzelan A; Phillip M
    J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
    Kunz GJ; Sherman TI; Klein KO
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of central precocious puberty treatment with GnRH analogue at the Triangulo Mineiro Federal University (UFTM).
    Borges Mde F; Franciscon Pde M; Cambraia TC; Oliveira DM; Ferreira BP; Resende EA; Palhares HM
    Arch Endocrinol Metab; 2015 Dec; 59(6):515-22. PubMed ID: 26421668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of HPGA suppression on predicted adult height in girls with central precocious puberty].
    Tao YH; Zeng BH; Sharif N
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1093-7. PubMed ID: 26483231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls.
    Fu J; Zhang J; Chen R; Ma X; Wang C; Chen L; Liang Y; Luo X; Yang Y; Xiong F; Su Z; Wu J; Yao H; Xu J; Wu D; Ni Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31702013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.
    Mul D; Oostdijk W; Otten BJ; Rouwé C; Jansen M; Delemarre-van de Waal HA; Waelkens JJ; Drop SL
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():765-72. PubMed ID: 10969919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.